2003
DOI: 10.1016/j.mrgentox.2003.07.005
|View full text |Cite
|
Sign up to set email alerts
|

Report from the in vitro micronucleus assay working group

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
169
0
13

Year Published

2008
2008
2018
2018

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 541 publications
(184 citation statements)
references
References 42 publications
2
169
0
13
Order By: Relevance
“…Stock solutions were prepared such that a consistent volume of solvent was added to each flask (from 100x solutions of SUC or MMC, prepared in water; or from 1000x solutions of DEX, VB, ETOPO, or STS, prepared in dimethyl sulfoxide). In all cases, cells were incubated at 37°C for 24 hrs (the length of time that is approximately 2.5 doubling times for untreated cells, as recommended by an expert working group [1]). …”
Section: Chemical Treatmentmentioning
confidence: 99%
See 2 more Smart Citations
“…Stock solutions were prepared such that a consistent volume of solvent was added to each flask (from 100x solutions of SUC or MMC, prepared in water; or from 1000x solutions of DEX, VB, ETOPO, or STS, prepared in dimethyl sulfoxide). In all cases, cells were incubated at 37°C for 24 hrs (the length of time that is approximately 2.5 doubling times for untreated cells, as recommended by an expert working group [1]). …”
Section: Chemical Treatmentmentioning
confidence: 99%
“…Relative survival calculations were made based on the mean concurrent solvent control cell density. As suggested by an expert working group and also draft OECD guidances [1,6], concentrations that resulted in > 60% reduction to relative survival were excluded from MN assessment.…”
Section: Cytotoxicity Measurementsmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, it is often necessary to perform the assay both in the presence and absence of Cyt‐B, which increases the number of samples that must be evaluated. In recent years, several protocols and exposure schedules to perform the MN assay have been developed and validated in a number of recommended cell types 9, 10, 11, 12. Current forms of the assay are able to detect the presence of clastogens and aneugens in both rodent and human derived cell lines as well as in human peripheral blood lymphocytes 13, 14, 15, 16, 17.…”
Section: Introductionmentioning
confidence: 99%
“…Cytochalasin B (final concentration of 6 lg/mL) was added after 44 h of incubation in order to block cytokinesis and obtain binucleated cells. After an additional 24 h incubation at 37°C, cells were harvested by centrifugation and slides were prepared for MN test (Fenech 2000;Kirsch-Volders et al 2003).…”
Section: Test Samples and Chemicalsmentioning
confidence: 99%